ZA200705561B - Stabilisation of radiopharmaceutical precursors - Google Patents

Stabilisation of radiopharmaceutical precursors

Info

Publication number
ZA200705561B
ZA200705561B ZA200705561A ZA200705561A ZA200705561B ZA 200705561 B ZA200705561 B ZA 200705561B ZA 200705561 A ZA200705561 A ZA 200705561A ZA 200705561 A ZA200705561 A ZA 200705561A ZA 200705561 B ZA200705561 B ZA 200705561B
Authority
ZA
South Africa
Prior art keywords
stabilisation
radiopharmaceutical precursors
radiopharmaceutical
precursors
Prior art date
Application number
ZA200705561A
Other languages
English (en)
Inventor
Wickstrom Lill Torild
Osborn Nigel John
Wilson Anthony
Dirk In T Veld
Grigg Julian
Original Assignee
Ge Healthcare As
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As, Ge Healthcare Ltd filed Critical Ge Healthcare As
Publication of ZA200705561B publication Critical patent/ZA200705561B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
ZA200705561A 2004-12-22 2007-07-06 Stabilisation of radiopharmaceutical precursors ZA200705561B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0428020.2A GB0428020D0 (en) 2004-12-22 2004-12-22 Stabilisation of radiopharmaceutical precursors

Publications (1)

Publication Number Publication Date
ZA200705561B true ZA200705561B (en) 2008-09-25

Family

ID=34112999

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200705561A ZA200705561B (en) 2004-12-22 2007-07-06 Stabilisation of radiopharmaceutical precursors

Country Status (17)

Country Link
US (2) US10000518B2 (xx)
EP (1) EP1843792B1 (xx)
JP (1) JP5047807B2 (xx)
KR (1) KR101318502B1 (xx)
CN (1) CN101084019B (xx)
AU (1) AU2005317986B2 (xx)
BR (1) BRPI0519582B8 (xx)
CA (1) CA2587839C (xx)
ES (1) ES2614747T3 (xx)
GB (1) GB0428020D0 (xx)
IL (1) IL183351A (xx)
MX (1) MX2007007564A (xx)
NO (1) NO341388B1 (xx)
NZ (1) NZ555220A (xx)
RU (1) RU2389510C2 (xx)
WO (1) WO2006067366A1 (xx)
ZA (1) ZA200705561B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0428020D0 (en) * 2004-12-22 2005-01-26 Amersham Health As Stabilisation of radiopharmaceutical precursors
WO2007148083A2 (en) * 2006-06-21 2007-12-27 Ge Healthcare As Stabilisation of radiopharmaceutical precursors
DE102007038333A1 (de) 2007-08-14 2009-02-19 Wacker Chemie Ag Silan-modifizierte Additive und Silanmodifizierte Polymerzusammensetzungen
BRPI0820438A2 (pt) * 2007-11-07 2015-06-16 Ge Healthcare Bv Composição radiofarmacêutica estabilizada, método para a preparação da mesma, e, uso de ácido gentísico ou um sal do mesmo com um cátion biocompatível.
USD623071S1 (en) 2009-07-16 2010-09-07 S.C. Johnson & Son, Inc. Container with overcap
GB201110239D0 (en) 2011-06-17 2011-08-03 College The Labelling method
KR101831420B1 (ko) 2015-07-09 2018-02-23 국민대학교산학협력단 음원 재생에 연계한 감성조명 색상의 조합생성 시스템 및 방법, 그리고 이를 위한 기록매체

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3424525A1 (de) 1984-07-04 1986-01-16 Kernforschungsanlage Jülich GmbH, 5170 Jülich Verfahren zur herstellung von (pfeil hoch)1(pfeil hoch)(pfeil hoch)8(pfeil hoch)f-alkyl- und arylverbindungen durch halogenaustausch
JPS63303911A (ja) * 1987-06-02 1988-12-12 Kao Corp ゲル状美爪料除去剤
JP2738224B2 (ja) * 1992-06-15 1998-04-08 日本鋼管株式会社 １８ｆ標識有機化合物の製造法
US5264570A (en) 1992-08-05 1993-11-23 General Electric Company Method for making 2-[18 F]fluoro-2-deoxy-D-glucose
US5457194A (en) 1993-03-17 1995-10-10 Abbott Laboratories Substituted aliphatic amine-containing macrocyclic immunomodulators
WO1994021653A1 (en) * 1993-03-22 1994-09-29 General Electric Company Method for making 2-fluoro-2-deoxyglucose
JP3008329B2 (ja) * 1995-01-26 2000-02-14 信彦 中澤 ラジオアイソトープ標識試薬調整用プレフィルドキット
DE69630400T2 (de) 1995-12-22 2005-04-14 University Technologies International Inc., Calgary Kupplungsarm für festträger oligonukleotid-synthese und verfahren zur herstellung davon
US5932178A (en) 1996-03-29 1999-08-03 Nkk Plant Engineering Corporation FDG synthesizer using columns
JP3133251B2 (ja) * 1996-03-29 2001-02-05 エヌケ−ケ−プラント建設株式会社 陽イオン交換樹脂カラム上で、溶媒除去と加水分解反応を同時に行うｆｄｇ合成装置
DE19815901A1 (de) * 1998-04-08 1999-10-14 Aventis Res & Tech Gmbh & Co Verfahren zur Herstellung von Pentopyranosyl-Nucleosiden
GB0228490D0 (en) * 2002-12-06 2003-01-08 Amersham Plc Novel imaging compounds
EP1444990A1 (en) 2003-02-07 2004-08-11 Amersham plc Improved Radiometal Complex Compositions
US7964568B2 (en) 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
FR2863876A1 (fr) * 2003-12-17 2005-06-24 Oreal Mascara comprenant un compose alkylpolyglycoside et/ou un pr produit o-acye du glucose
FR2864898B1 (fr) * 2004-01-09 2006-03-24 Expanscience Lab Composition de type ecran solaire organo-mineral adaptee pour l'application par pompe de propulsion
GB0428020D0 (en) * 2004-12-22 2005-01-26 Amersham Health As Stabilisation of radiopharmaceutical precursors

Also Published As

Publication number Publication date
US20150018541A1 (en) 2015-01-15
GB0428020D0 (en) 2005-01-26
NO20073156L (no) 2007-07-19
US9969761B2 (en) 2018-05-15
KR101318502B1 (ko) 2013-10-16
RU2007120464A (ru) 2009-01-27
NO341388B1 (no) 2017-10-30
AU2005317986A1 (en) 2006-06-29
BRPI0519582B8 (pt) 2021-07-27
BRPI0519582A2 (pt) 2009-02-17
ES2614747T3 (es) 2017-06-01
BRPI0519582B1 (pt) 2016-10-04
US10000518B2 (en) 2018-06-19
CN101084019A (zh) 2007-12-05
CN101084019B (zh) 2010-10-06
AU2005317986B2 (en) 2011-08-11
RU2389510C2 (ru) 2010-05-20
MX2007007564A (es) 2007-08-15
IL183351A (en) 2013-07-31
NZ555220A (en) 2011-05-27
JP5047807B2 (ja) 2012-10-10
US20100029930A1 (en) 2010-02-04
EP1843792B1 (en) 2017-01-04
IL183351A0 (en) 2007-09-20
JP2008525393A (ja) 2008-07-17
WO2006067366A1 (en) 2006-06-29
CA2587839A1 (en) 2006-06-29
CA2587839C (en) 2015-04-28
KR20070091627A (ko) 2007-09-11
EP1843792A1 (en) 2007-10-17

Similar Documents

Publication Publication Date Title
EP1778618A4 (en) SYNTHESIS OF TRIETHYLENETETRAMINES
HK1083341A1 (en) Stable crystal of 4-oxoquinoline compound
IL185747A0 (en) Use of supplemental assignments
IL184036A0 (en) Preparation of rosuvastatin
SI1802579T1 (sl) Derivati 3-arilaminopiridina
EP1785131A4 (en) EXTERNAL PREPARATION OF TYPE S / O
IL185018A0 (en) Break-resistant delayed-release forms of administration
PL1778621T3 (pl) Wytwarzanie jodiksanolu
EP1711484A4 (en) SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
ZA200705561B (en) Stabilisation of radiopharmaceutical precursors
HK1161122A1 (en) Use of 24-norudca 24-norudca
EP1850663A4 (en) USE OF MINOXIDILSULFATE AS AN ACTIVE AGAINST CANCER
IL187948A0 (en) Preparation of rosuvastatin
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
GB0612306D0 (en) Stabilisation of radiopharmaceutical precursors
SI1709057T1 (sl) Sinteza spongozina
TWM291268U (en) Improvement of pillow structure
GB0500479D0 (en) New medical use of triazine compound
TWM291990U (en) Structure improvement of lock
GB0413190D0 (en) Stabilisation of putrescible materials
TWM292330U (en) Improvement of bed-chair structure
PL369353A1 (pl) Zestaw elementów budowlanych
GB0400471D0 (en) Compound libraries
GB0412962D0 (en) Compound libraries
GB0416321D0 (en) Compound libraries